Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2012-12-06 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GRASSE (06130), Alpes-Maritimes
PHARMACIE PP2G : revenue, balance sheet and financial ratios
PHARMACIE PP2G is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GRASSE (06130),
this company of category PME
shows in 2022 a revenue of 6.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PP2G (SIREN 789798139)
Indicator
2024
2023
2022
2021
2020
2019
2019
2018
2017
2016
Revenue
N/C
N/C
6 851 841 €
N/C
5 446 708 €
3 115 643 €
5 305 061 €
4 952 464 €
4 897 719 €
4 811 705 €
Net income
645 467 €
632 184 €
681 679 €
820 115 €
490 066 €
221 029 €
397 029 €
302 510 €
308 759 €
249 941 €
EBITDA
N/C
N/C
984 068 €
N/C
730 916 €
356 915 €
585 826 €
481 173 €
511 549 €
429 822 €
Net margin
N/C
N/C
9.9%
N/C
9.0%
7.1%
7.5%
6.1%
6.3%
5.2%
Revenue and income statement
In 2024, PHARMACIE PP2G generates positive net income of 645 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 250 k€ -> 645 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
645 467 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 93%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
92.616%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
43.342%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2019
2020
2021
2022
2023
2024
Debt ratio
156.872
121.053
94.54
70.007
206.584
168.464
121.822
91.677
69.909
92.616
Financial autonomy
34.431
40.324
44.905
51.493
29.337
31.923
36.826
44.133
48.772
43.342
Repayment capacity
11.251
8.376
8.056
5.205
15.318
6.775
None
4.014
None
None
Cash flow / Revenue
5.616%
6.628%
6.04%
7.471%
7.219%
9.117%
None%
9.883%
None%
None%
Sector positioning
Debt ratio
92.622024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE PP2G (92.62) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
43.34%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE PP2G (43.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.01 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE PP2G (4.01) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 199.63. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
199.629
Liquidity indicators evolution PHARMACIE PP2G
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2019
2020
2021
2022
2023
2024
Liquidity ratio
143.428
147.065
135.495
144.021
173.653
172.979
168.219
193.808
198.491
199.629
Interest coverage
16.918
11.584
9.586
6.867
10.908
1.981
None
1.247
None
None
Sector positioning
Liquidity ratio
199.632024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good+8 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE PP2G (199.63) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.25x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE PP2G (1.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PP2G
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2019
2020
2021
2022
2023
2024
Operating WCR
411 834 €
477 234 €
495 197 €
494 591 €
548 602 €
487 480 €
0 €
943 499 €
0 €
0 €
Inventory turnover (days)
31
34
34
32
50
39
0
42
0
0
Customer payment term (days)
5
4
5
4
7
4
0
4
0
0
Supplier payment term (days)
48
48
55
54
75
58
0
60
0
0
Positioning of PHARMACIE PP2G in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE PP2G is estimated at
9 011 196 €
(range 6 275 254€ - 13 481 265€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
6275k€9011k€13481k€
9 011 196 €Range: 6 275 254€ - 13 481 265€
NAF 5 année 2024
Valuation method used
Net Income Multiple
645 467 €
×
14.0x
=9 011 197 €
Range: 6 275 255€ - 13 481 266€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PP2G with other companies in the same sector:
Yes, PHARMACIE PP2G generated a net profit of 645 k€ in 2024.
Where is the headquarters of PHARMACIE PP2G ?
The headquarters of PHARMACIE PP2G is located in GRASSE (06130), in the department Alpes-Maritimes.
Where to find the tax return of PHARMACIE PP2G ?
The tax return of PHARMACIE PP2G is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PP2G operate?
PHARMACIE PP2G operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart